NKTR
Nektar TherapeuticsstockNASDAQ
At CloseNov 18, 2026 3:59:59 PM EST
34.45USD-4.066%(-1.46)811,351
After-hoursNov 18, 2026 4:00:30 PM EST
34.42USD-0.087%(-0.03)
Loading…
Loading…
1.18B
Healthcare
Biotechnology
CEO
Howard Robin
HQ
San Francisco, CA, USA
509
Previous Close
$35.91
Beta
1.04
52-Week High
$109.00 2026-04-20
52-Week Low
$33.40 2026-01-30
SMA 50
$46.15
SMA 200
$65.01
Avg. Vol 10D
689,523
Avg. Vol 30D
791,066
Avg. Vol 90D
982,882
Relative Vol
1.03
34.21M
29.14M
85.17%
6,766,027
23.22%
10.26
58%/42%
54.94%
37.78%
0.2800%
1,600,000
3,173
7,340
34,139
Jun 9, 2025 · 1-for-15 (reverse)
52.2M
-177.3M
-6.31
-257.5M
-319.75
-37.92
Nov 17, 2026
Nov 16, 2026
Nov 14, 2026
Nov 13, 2026
Nektar (NKTR) Q3 2026 Earnings Call Transcript ·
The Motley Fool
NKTR Profile
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
NKTR Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 37.25 | 2026-11-12 | -7.52% | -0.005 |
| 1M | 36.64 | 2026-10-19 | -5.98% | 1.265 |
| 3M | 76.08 | 2026-08-19 | -54.72% | 0.963 |
| 6M | 67.58 | 2026-05-19 | -49.02% | 0.956 |
| 1Y | 60.35 | 2025-11-19 | -42.92% | 1.044 |
| 2Y | 15.45 | 2024-11-19 | +122.98% | — |
| 5Y | 177.00 | 2021-11-19 | -80.54% | 1.701 |
NKTR Stock Summary
Nektar Therapeutics (NASDAQ:NKTR) stock price today is $34.45, and today's volume is 811,351. NKTR is down 4.066% today. The 30 day average volume is 791,066. NKTR market cap is $1.18B with 34.21M shares outstanding.
